Vyant Bio, Inc.
DelistedCIK 1349929fmd_10S180ZT7N38WF1A91QB5QH1YWServices · Services-Medical LaboratoriesTemplate: Standard
Coverage: Jan 01, 2011 to Dec 31, 2022, 45 periods
| Line item | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 7 | 10 | 18 | 27 | 29 | 5 | 7 | 1 | 1 | 1 |
| Cost of revenue | 5 | 8 | 14 | 17 | 18 | 3 | 4 | 3 | – | – |
| Net interest income | – | – | – | – | – | – | – | (1) | (0) | 0 |
| Gross profit | 2 | 2 | 4 | 10 | 11 | 2 | 4 | 2 | – | – |
| Research and development | 2 | 5 | 5 | 6 | 5 | 0 | 0 | 3 | 4 | 7 |
| Selling, general and administrative | 8 | 16 | 20 | 21 | 25 | 8 | 6 | 8 | – | – |
| Total operating expenses | 10 | 21 | 25 | 27 | 30 | 10 | 9 | 8 | 17 | 17 |
| Operating income | (8) | (19) | (21) | (17) | (19) | (8) | (6) | (8) | (16) | (16) |
| Interest expense | 2 | 0 | 0 | 0 | 2 | 0 | 1 | 0 | – | – |
| Interest and investment income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | – | – |
| Other non-operating income (expense) | (5) | 0 | 0 | 1 | (4) | 3 | (2) | (1) | (3) | 0 |
| Income before taxes | – | – | – | – | – | – | – | (9) | (19) | (16) |
| Income tax expense | (1) | (2) | (1) | 0 | (2) | 0 | (1) | 0 | – | – |
| Net income from continuing operations | – | – | – | – | – | (4) | (7) | (9) | (19) | (16) |
| Net income | (12) | (17) | (20) | (16) | (21) | (20) | (7) | (9) | (41) | (23) |
| Net income to common shareholders | (17) | (17) | (20) | (16) | – | – | – | – | – | – |